Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TP53BP2 encodes a member of the ASPP (apoptosis-stimulating protein of p53) family of p53 interacting proteins. Additionally we are shipping Tumor Protein P53 Binding Protein 2 Proteins (3) and Tumor Protein P53 Binding Protein 2 Kits (2) and many more products for this protein.
Showing 10 out of 68 products:
Dog (Canine) Polyclonal TP53BP2 Primary Antibody for EIA, WB - ABIN401045
Liu, Lu, Zhang, Zhong, Gu, Zhang, Yang, Xin: Downregulated mRNA expression of ASPP and the hypermethylation of the 5'-untranslated region in cancer cell lines retaining wild-type p53. in FEBS letters 2005
Show all 5 references for ABIN401045
Human Monoclonal TP53BP2 Primary Antibody for IF, WB - ABIN968491
Iwabuchi, Li, Massa, Trask, Date, Fields: Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. in The Journal of biological chemistry 1998
Show all 3 references for ABIN968491
Human Polyclonal TP53BP2 Primary Antibody for EIA, WB - ABIN955298
Hirata, Hinoda, Nakajima, Kikuno, Suehiro, Tabatabai, Ishii, Dahiya: The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer. in The Journal of urology 2009
Show all 3 references for ABIN955298
Cow (Bovine) Polyclonal TP53BP2 Primary Antibody for WB - ABIN2780683
Ju, Lee, Yang, Kim, Kang, Sohn, Rhee, Kang, Kim: TP53BP2 locus is associated with gastric cancer susceptibility. in International journal of cancer. Journal international du cancer 2005
Human Polyclonal TP53BP2 Primary Antibody for IHC, ELISA - ABIN1584022
Matsumoto, Weckbecker, Cory: Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells. in Cancer communications 1990
These findings uncover a novel role of Aspp2 in regulating vertebrate embryonic growth.
After genotoxic stress, Aspp1 (show PPP1R13B Antibodies) promotes hematopoietic stem cell (HSC (show FUT1 Antibodies)) cycling and induces p53 (show TP53 Antibodies)-dependent apoptosis in cells with persistent DNA damage foci. Aspp1 (show PPP1R13B Antibodies) also attenuates HSC (show FUT1 Antibodies) self-renewal and accumulation of DNA damage in p53 (show TP53 Antibodies) null HSCs.
ASPP2 may participate in the lipid metabolism of non-alcoholic steatohepatitis and attenuate liver failure.
ASPP2 prevents beta-catenin (show CTNNB1 Antibodies) from transactivating ZEB1 (show ZEB1 Antibodies) directly by forming an ASPP2-beta-catenin (show CTNNB1 Antibodies)-E-cadherin (show CDH1 Antibodies) ternary complex
findings suggest that the identified STAT1 (show STAT1 Antibodies)/ASPP2 pathway may connect tumor suppression and cell polarity to neuroinflammation
our studies demonstrate the role of Siah2 (show SIAH2 Antibodies) in regulation of tight junction integrity and cell polarity under hypoxia, through its regulation of ASPP2 stability.
ASPP2 is a tumor suppressor that suppresses squamous cell carcinoma via inflammatory signaling through NF-kappaB (show NFKB1 Antibodies)-mediated repression of p63 (show CKAP4 Antibodies).
Our study demonstrates a novel role for ASPP1 (show PPP1R13B Antibodies) and ASPP2 in the death of retinal ganglion cells.
regulates epithelial cell polarity in cooperation with PAR-3 (show F2RL2 Antibodies) to form an active PAR (show AFG3L2 Antibodies) complex
Consistent with its role in cell polarity, ASPP2 influences interkinetic nuclear migration and lamination during CNS development.
Aspp1 (show PPP1R13B Antibodies) plays a crucial role in the initial assembly and function of lymphatic vessels during mouse development in a p53 (show TP53 Antibodies)-independent manner.
miR (show MLXIP Antibodies)-548d-3p/TP53BP2 pathway is critically involved in the proliferation and apoptosis of breast cancer cells and may be new therapeutic target of breast cancer cells.
ASPP1 (show PPP1R13B Antibodies)/2-PP1 (show PPA1 Antibodies) complexes are required for chromosome segregation and kinetochore-microtubule attachments.
ASSP2 expression is lower in cancerous tissues and decreased ASPP2 lead to higher cancer cells proliferation and autophagic flux, which contribute to the gemcitabine resistance.
this study revealed a novel function of ASPP2 in modulating autophagy and apoptosis.
These results identify previously uncharacterized regions distributed throughout the protein sequence of ASPP2 as determinants of CagA (show S100A8 Antibodies) binding, providing mechanistic insight into apoptosis reprogramming by CagA (show S100A8 Antibodies).
ASPP2 directly induces the dephosphorylation and activation of junctional YAP (show YAP1 Antibodies)
CHOP (show DDIT3 Antibodies) is critical for mediating ASPP2-induced autophagic apoptosis by decreasing Bcl-2 (show BCL2 Antibodies) expression and maintaining nuclear ASPP2-Bcl-2 (show BCL2 Antibodies) complexes.
ASPP1 (show PPP1R13B Antibodies)/2 interacted with centrosome linker protein (show LAT Antibodies) C (show PROC Antibodies)-Nap1 (show CEP250 Antibodies). Co-depletion of ASPP1 (show PPP1R13B Antibodies) and ASPP2 inhibited re-association of C-Nap1 (show CEP250 Antibodies) with centrosome at the end of mitosis.
these observations reveal that Itch and Yap1 (show YAP1 Antibodies) have antagonistic roles in the regulation of ASPP2 protein stability through competing post-translational regulatory mechanism of ASPP2.
This gene encodes a member of the ASPP (apoptosis-stimulating protein of p53) family of p53 interacting proteins. The protein contains four ankyrin repeats and an SH3 domain involved in protein-protein interactions. It is localized to the perinuclear region of the cytoplasm, and regulates apoptosis and cell growth through interactions with other regulatory molecules including members of the p53 family. Multiple transcript variants encoding different isoforms have been found for this gene.
tumor protein p53 binding protein, 2
, apoptosis-stimulating of p53 protein 2-like
, apoptosis-stimulating of p53 protein 1
, protein phosphatase 1 regulatory subunit 13B
, transformation related protein 53 binding protein 2
, tumor protein p53-binding protein, 2
, apoptosis-stimulating of p53 protein 2
, p53-binding protein 2
, tumor suppressor p53-binding protein 2
, BCL2-binding protein
, apoptosis-stimulating protein of p53, 2
, renal carcinoma antigen NY-REN-51